FDA Clearance Tracker · P010013-S058
NOVASURE IMPEDANCE CONTROLLED EDOMETRIAL ABLATION SYSTEM
Last checked: Nov 20, 2026Latest source record: Oct 28, 2014 (this decision)Source: openFDAMethods & limitations
Decided
Oct 28, 2014
Approved
Time to decision
93 days
Received Jul 27, 2014. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P010013-S058
- Device name
- NOVASURE IMPEDANCE CONTROLLED EDOMETRIAL ABLATION SYSTEM
- Applicant
- Hologic, Inc.
- Applicant location
- Malborough, MA
- Received
- Jul 27, 2014
- Decided
- Oct 28, 2014
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P010013
Device type
- Device type
- Device, thermal ablation, endometrial (MNB)
- Device class
- Class III
- Specialty
- Obstetrics & Gynecology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR DEVICE MODIFICATIONS, INCLUDING FLATTENING OF THE NVSRAM BATTERY CLIP AND ADDITION OF KAPTON TAPE TO THE NVSRAM BATTERY AND THE UI BOARD SHIELD TO OVERCOME A DEVICE ERROR OCCURRING IF CONTACT OF THESE COMPONENTS OCCURS.
Source documents
Other decisions for Hologic, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- I-View®510(k)
K254090 · Decided Sep 2, 2026 · 257 days after receipt
Device type: Full Field Digital, System, X-Ray, Mammographic (MUE) · Radiology & Imaging
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.